Transcode Therapeutics Inc (RNAZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,817 | -17,565 | -12,431 | -8,141 | -3,470 |
| Depreciation Amortization | 100 | 99 | 69 | 44 | 22 |
| Other Working Capital | 44 | 1,309 | 354 | 617 | -561 |
| Other Operating Activity | 159 | 395 | 265 | 159 | 61 |
| Operating Cash Flow | $-4,514 | $-15,763 | $-11,743 | $-7,321 | $-3,949 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -13 | -101 | -73 | -73 | -31 |
| Investing Cash Flow | $-13 | $-101 | $-73 | $-73 | $-31 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,181 | 6 | 6 | 6 | 6 |
| Other Financing Activity | 0 | 0 | -226 | 0 | 0 |
| Financing Cash Flow | $1,181 | $6 | $-220 | $6 | $6 |
| Beginning Cash Position | 4,968 | 20,826 | 20,826 | 20,826 | 20,826 |
| End Cash Position | 1,623 | 4,968 | 8,791 | 13,438 | 16,853 |
| Net Cash Flow | $-3,346 | $-15,857 | $-12,035 | $-7,388 | $-3,973 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,514 | -15,763 | -11,743 | -7,321 | -3,949 |
| Capital Expenditure | -13 | -101 | -73 | -73 | -31 |
| Free Cash Flow | -4,527 | -15,863 | -11,816 | -7,394 | -3,979 |